Diabetology competitorsClear all

MannKind Corporation's top competitors include Sensulin, Inversago Pharma and Diasome.

Save Comparison	MannKind Corporation MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.	Sensulin Sensulin is a biotechnology company developing insulin for diabetes.	Inversago Pharma Inversago Pharma is a specialized, preclinical-stage biotech company.	Diasome Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity.
Founding Date	Founding Date 1991	Founding Date 2011	Founding Date 2015	Founding Date 2004
Type	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech diabetes drug development pharma	Tags Healthcare biotech diabetes drug development pharma	Tags Healthcare cannabis diabetes drug development pharma	Tags Healthcare biotech diabetes drug development pharma
Locations	Locations Westlake Village, US HQ Danbury, US	Locations Oklahoma City, US HQ	Locations Montreal, CA HQ	Locations Cleveland, US HQ
Employees	Employees 2323% increase	Employees 4	Employees 5	Employees 8
Twitter followers	Twitter followers 2.6 k	Twitter followers 109	Twitter followers 137	Twitter followers 4.6 k
Number of tweets (last 30 days)	Number of tweets (last 30 days) 1	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 2	Number of tweets (last 30 days) N/A
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 15	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 2	Average likes per tweet (last 30 days) N/A
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A
Alexa Website Rank	Alexa Website Rank 223694	Alexa Website Rank N/A	Alexa Website Rank 467909	Alexa Website Rank N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 2.7m (about 5 years ago)	Latest funding round $ 35m (5 months ago)	Latest funding round $ 30m (over 3 years ago)
Total funding raised	Total funding raised $ 200m	Total funding raised $ 3.1m	Total funding raised $ 42m	Total funding raised $ 42.9m